Australia Markets open in 6 hrs 37 mins

Isoray, Inc. (ISR)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.4200-0.0280 (-6.25%)
As of 04:00PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.4480
Open0.4416
Bid0.4300 x 1300
Ask0.4255 x 1000
Day's range0.4200 - 0.4416
52-week range0.4000 - 2.8100
Volume856,258
Avg. volume737,509
Market cap59.304M
Beta (5Y monthly)1.05
PE ratio (TTM)N/A
EPS (TTM)-0.0460
Earnings date13 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.17
  • Zacks

    IsoRay (ISR) Reports Q1 Loss, Lags Revenue Estimates

    IsoRay (ISR) delivered earnings and revenue surprises of -100.00% and -0.54%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Isoray Announces First Quarter Fiscal 2022 Financial Results

    Prostate Revenue Increased Year-Over-Year for Second Consecutive QuarterNon-Prostate Brachytherapy Revenue Increased 20% Year-Over-Year RICHLAND, Wash., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced its financial results for the first quarter fiscal 2022 ended September 30, 2021. Revenue for the first quarter of fiscal 2022 grew 8% to $

  • Zacks

    Will IsoRay (ISR) Report Negative Earnings Next Week? What You Should Know

    IsoRay (ISR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.